Submission Details
| 510(k) Number | K203432 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2020 |
| Decision Date | July 07, 2021 |
| Days to Decision | 226 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K203432 is an FDA 510(k) clearance for the Axium Detachable Coil; Axium Prime Detachable Coil, a Device, Neurovascular Embolization (Class II — Special Controls, product code HCG), submitted by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular (Irvine, US). The FDA issued a Cleared decision on July 7, 2021, 226 days after receiving the submission on November 23, 2020. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5950.
| 510(k) Number | K203432 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 23, 2020 |
| Decision Date | July 07, 2021 |
| Days to Decision | 226 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | HCG — Device, Neurovascular Embolization |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5950 |